Impact of dupilumab prescribing on utilization of medical and surgical therapies for chronic rhinosinusitis with nasal polyps

Christopher M. Low, Allan R. Wang,Michael Yong,Jayakar Nayak,Zara Patel,Peter H. Hwang

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY（2024）

引用 0|浏览9

暂无评分

摘要

Key points Increased dupilumab utilization coincided with decreased ESS in patients with CRSwNP between 2019 and 2021. One potential confounder was the concurrent COVID-19 pandemic, which may have negatively impacted surgery utilization rates.

查看译文

关键词

chronic rhinosinusitis,endoscopic sinus surgery,eosinophilic rhinitis and nasal polyposis,FESS,medical therapy of chronic rhinosinusitis,therapeutics

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要